English
Dr Reddy's Laboratories Q1 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,199.80
-5.50 (-0.46%)
-5.50 (-0.46%)Volume12.28 K
Updated: Mon 10 Nov, 2025 | 13:53:11
NSE
1,199.80-5.60 (-0.46%)
-5.60 (-0.46%)Volume1.11 M
Updated: Mon 10 Nov, 2025 | 13:39:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr Reddy's Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6,874.60 | 6,944.70 | -1.01% | 5,946.80 | 15.60% |
| Depreciation/ Amortization | 476.10 | 454.70 | 4.71% | 380.60 | 25.09% |
| Operating Income | 1,697.50 | 1,583.70 | 7.19% | 1,749.30 | -2.96% |
| Net Income | 1,418.10 | 1,593.30 | -11.00% | 1,392.40 | 1.85% |
| Other Operating Expenses Total | 2,087.50 | 2,162.60 | -3.47% | - | N/A |
| Net Income Before Taxes | 1,905.00 | 2,005.20 | -5.00% | 1,882.60 | 1.19% |
| Total Revenue | 8,572.10 | 8,528.40 | 0.51% | 7,696.10 | 11.38% |
| Selling/ General/ Admin Expenses Total | 1,503.50 | 1,400.60 | 7.35% | 3,384.00 | -55.57% |
| Diluted Normalized EPS | 17.02 | 19.83 | -14.18% | 16.70 | 1.91% |